Overview
TB-500 and BPC-157 are two of the most widely researched peptides in the sports science and tissue repair literature. While both have been studied for their healing properties, they operate through different mechanisms and appear to have different tissue affinities.
What is TB-500?
TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a 43-amino-acid peptide that is naturally present in virtually every cell in the human body. It is particularly abundant in wound fluid and platelets. Its primary mechanism involves actin binding — specifically, TB-500 sequesters actin monomers (G-actin), influencing cell migration, differentiation, and survival.
What is BPC-157?
BPC-157 is a 15-amino-acid peptide derived from a portion of human gastric juice protein. It does not occur naturally in the body at measurable levels. Its mechanisms are broader and more systemic, with documented effects on tendon, muscle, bone, gut, and neurological tissue in animal models.
Key Differences
FeatureBPC-157TB-500 OriginGastric juice protein fragmentThymosin Beta-4 fragment Size15 amino acids43 amino acids Primary mechanismNO system, angiogenesisActin binding, cell migration Systemic vs localBoth systemic and localMore systemic
Research Conclusion
Both peptides have shown impressive results in preclinical models. Many researchers study them in combination due to their complementary mechanisms.
